Windlas Biotech Limited WINDLAS

Latest filings

• Routine15 6 Nov, 20:35 · NSE
  Link of Recording
• Management change38 5 Nov, 18:27 · NSE
  Resignation of Director/KMP/SMP
• Results76 5 Nov, 17:52 · NSE
  A press release dated November 05, 2026, titled "Windlas Biotech Limited Reports its H1 & Q2 FY27 Financial Results".
• Management change38 5 Nov, 17:25 · BSE
  Mr. Ashok Kumar Windlass, has been appointed, as Founder President (Senior Management Personnel) of the Company, effective from November 6, 2026.
• Management change73 5 Nov, 17:18 · BSE
  resignation of Mr. Ashok Kumar Windlass (DIN: 00011451) from the position of Whole-time Director and Director of the Company with effect from November 5, 2026 at 10.00 A.M.
• Routine15 5 Nov, 17:04 · NSE
  Investor Presentation
• Results73 5 Nov, 16:27 · BSE
  Approval inter alia unaudited financial results for the quarter and half year ended September 30, 2026
• Results76 5 Nov, 16:18 · BSE
  The Board approved inter alia financial results for the quarter and half year ended September 30 2026.
• General25 30 Oct, 19:03 · BSE
  Intimation of Cyber Security Incident
• Routine15 30 Oct, 12:49 · NSE
  Schedule of meet

Shown 15 minutes after publication. Real time with Pro.